Structural Parameters Governing Activity of Pluronic Triblock Copolymers in Hyperthermia Cancer Therapy

Overview

Journal Int J Hyperthermia

Publisher Informa Healthcare

Specialties Oncology
Pharmacology

Date 2011 Oct 14

PMID 21992559

Citations 9

Authors

Tianyi M Krupka

Agata A Exner

Affiliations

Soon will be listed here.

Abstract

Purpose: To identify specific Pluronic triblock copolymer structural properties which are critical to its function as a sensitiser in hyperthermia treatment of experimental colorectal adenocarcinoma.

Materials And Methods: DHD/K12/TRb rat colorectal adenocarcinoma cells were exposed to Pluronics, a family of triblock copolymers with the general structure EO(x)-PO(y)-EO(x) (EO: ethylene oxide, and PO: propylene oxide), at a range of molecular weights (Mw) and EO:PO:EO sub-unit lengths and then submitted to sublethal heat (43°C) treatment. Outcomes indicating Pluronic performance as a thermal sensitiser were correlated with its structural properties; lead candidates were determined accordingly. Finally, one of the lead candidates, Pluronic L61, a 2000 Da copolymer, was used to assess sensitising functionality in vivo in a subcutaneous rat model of colorectal carcinoma.

Results: Pluronics with 1100 ≤ Mw ≤ 3200 Da and hydrophilic lipophilic balance (HLB) between 1-8 demonstrated the highest thermosensitising ability. Pluronics L31, L61, L62, L10 and L64 were found to be among the most effective copolymers for hyperthermia sensitisation under tested conditions. Most encouraging, L61 in synergy with hyperthermia significantly reduced tumour growth progression in vivo compared to tumours treated with hyperthermia alone.

Conclusions: Pluronic copolymer structure properties including, Mw, HLB and PO length are essential to its hyperthermia sensitising function.

Citing Articles

The Development and Study of Some Composite Membranes Based on Polyurethanes and Iron Oxide Nanoparticles.

Gradinaru L, Vlad S, Ciobanu R Membranes (Basel). 2022; 12(11).

PMID: 36363682 PMC: 9695552. DOI: 10.3390/membranes12111127.

Surfactant-assisted individualization and dispersion of boron nitride nanotubes.

Smith McWilliams A, de Los Reyes C, Liberman L, Ergulen S, Talmon Y, Pasquali M Nanoscale Adv. 2022; 1(3):1096-1103.

PMID: 36133196 PMC: 9473271. DOI: 10.1039/c8na00315g.

Formulation and Characterization of Stimuli-Responsive Lecithin-Based Liposome Complexes with Poly(acrylic acid)/Poly(,-dimethylaminoethyl methacrylate) and Pluronic Copolymers for Controlled Drug Delivery.

Simoes M, Hugo A, Gomez-Zavaglia A, Simoes P, Alves P Pharmaceutics. 2022; 14(4).

PMID: 35456569 PMC: 9029292. DOI: 10.3390/pharmaceutics14040735.

Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches.

Yi G, Kim M, Kim H, Park J, Baek S Antioxidants (Basel). 2022; 11(4).

PMID: 35453310 PMC: 9030926. DOI: 10.3390/antiox11040625.

Pluronics and MDR reversal: an update.

Alakhova D, Kabanov A Mol Pharm. 2014; 11(8):2566-78.

PMID: 24950236 PMC: 4122590. DOI: 10.1021/mp500298q.

References

Batrakova E, Li S, Elmquist W, Miller D, Alakhov V, Kabanov A . Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. Br J Cancer. 2001; 85(12):1987-97. PMC: 2364003. DOI: 10.1054/bjoc.2001.2165. View

Flanders V, Gervais D . Ablation of liver metastases: current status. J Vasc Interv Radiol. 2010; 21(8 Suppl):S214-22. DOI: 10.1016/j.jvir.2010.01.046. View

Goldberg S, Gazelle G . Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology. 2001; 48(38):359-67. View

Batrakova E, Li S, Li Y, Alakhov V, Elmquist W, Kabanov A . Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J Control Release. 2004; 100(3):389-97. DOI: 10.1016/j.jconrel.2004.09.002. View

Batrakova E, Li S, Alakhov V, Miller D, Kabanov A . Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J Pharmacol Exp Ther. 2003; 304(2):845-54. DOI: 10.1124/jpet.102.043307. View

Marin A, Sun H, Husseini G, Pitt W, Christensen D, Rapoport N . Drug delivery in pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake. J Control Release. 2002; 84(1-2):39-47. DOI: 10.1016/s0168-3659(02)00262-6. View

Weinberg B, Krupka T, Haaga J, Exner A . Combination of sensitizing pretreatment and radiofrequency tumor ablation: evaluation in rat model. Radiology. 2008; 246(3):796-803. DOI: 10.1148/radiol.2463070228. View

Husseini G, Runyan C, Pitt W . Investigating the mechanism of acoustically activated uptake of drugs from Pluronic micelles. BMC Cancer. 2002; 2:20. PMC: 126246. DOI: 10.1186/1471-2407-2-20. View

Batrakova E, Li S, Alakhov V, Elmquist W, Miller D, Kabanov A . Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. Pharm Res. 2003; 20(10):1581-90. PMC: 3070744. DOI: 10.1023/a:1026179132599. View

10.

Bruners P, Lipka J, Gunther R, Schmitz-Rode T, Mahnken A . Bipolar radiofrequency ablation: is the shape of the coagulation volume different in comparison to monopolar RF-ablation using variable active tip lengths?. Minim Invasive Ther Allied Technol. 2008; 17(5):267-74. DOI: 10.1080/13645700802384122. View

11.

Kabanov A, Batrakova E, Alakhov V . An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. J Control Release. 2003; 91(1-2):75-83. PMC: 3932490. DOI: 10.1016/s0168-3659(03)00211-6. View

12.

Kabanov A, Batrakova E, Alakhov V . Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev. 2002; 54(5):759-79. DOI: 10.1016/s0169-409x(02)00047-9. View

13.

Krupka T, Solorio L, Wilson R, Wu H, Azar N, Exner A . Formulation and characterization of echogenic lipid-Pluronic nanobubbles. Mol Pharm. 2009; 7(1):49-59. PMC: 3285380. DOI: 10.1021/mp9001816. View

14.

Batrakova E, Lee S, Li S, Venne A, Alakhov V, Kabanov A . Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res. 1999; 16(9):1373-9. DOI: 10.1023/a:1018942823676. View

15.

Wu H, Exner A, Krupka T, Weinberg B, Haaga J . Vasomodulation of tumor blood flow: effect on perfusion and thermal ablation size. Ann Biomed Eng. 2008; 37(3):552-64. PMC: 3294296. DOI: 10.1007/s10439-008-9605-x. View

16.

Alakhov VYu , Moskaleva EYu , Batrakova E, Kabanov A . Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjug Chem. 1996; 7(2):209-16. DOI: 10.1021/bc950093n. View

17.

Katz D, Marcelletti J, Khalil M, Pope L, Katz L . Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex. Proc Natl Acad Sci U S A. 1991; 88(23):10825-9. PMC: 53024. DOI: 10.1073/pnas.88.23.10825. View

18.

Zytoon A, Ishii H, Murakami K, El-Kholy M, Furuse J, El-Dorry A . Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Jpn J Clin Oncol. 2007; 37(9):658-72. DOI: 10.1093/jjco/hym086. View

19.

Krupka T, Dremann D, Exner A . Time and dose dependence of pluronic bioactivity in hyperthermia-induced tumor cell death. Exp Biol Med (Maywood). 2008; 234(1):95-104. PMC: 3293626. DOI: 10.3181/0807-RM-223. View

20.

Euhus D, Hudd C, LaRegina M, Johnson F . Tumor measurement in the nude mouse. J Surg Oncol. 1986; 31(4):229-34. DOI: 10.1002/jso.2930310402. View